Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

4.1K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.1K
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

535
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
535
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

11.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K
Complement System01:27

Complement System

10.8K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
10.8K
Complementation Tests00:49

Complementation Tests

6.3K
A complementation test is a simple cross to identify whether the two mutations are located on the same gene or different genes. It was first performed by Edward Lewis in the 1940s while working on fruit flies. He developed the test to identify the location and arrangement of different mutations on chromosomes.
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
6.3K
Design Consideration01:22

Design Consideration

582
Designing a structure involves a series of considerations, primarily the material's ultimate strength, calculated through tests that measure changes under increased force until the material reaches its breaking point or limit. The ultimate load, where the material breaks, is divided by its original cross-sectional area, resulting in the ultimate normal stress or strength. The ultimate shearing stress is another significant factor taken into account.
The factor of safety is another key...
582

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Pegcetacoplan for Adolescents with C3 Glomerulopathy or Primary Immune Complex Membranoproliferative GN: Phase 3 VALIANT Subgroup Analysis.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Comparing Efficacy and Safety of Itraconazole Solution Versus Posaconazole for Antifungal Prophylaxis After Heart Transplant.

Open forum infectious diseases·2026
Same author

A nephritic puzzle: C3-dominant glomerulonephritis as a sentinel of hidden autoinflammatory disease.

Pediatric nephrology (Berlin, Germany)·2026
Same author

Strategies to Mitigate Infection Risk in Patients Receiving Complement Inhibitor Therapy.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Proteinuria Trajectory and Disease Progression in Children and Adults with IgA Nephropathy/Vasculitis.

Clinical journal of the American Society of Nephrology : CJASN·2025
Same author

Post-transplant Thrombotic Microangiopathy.

Journal of the American Society of Nephrology : JASN·2025

相关实验视频

Updated: Feb 8, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

18.7K

用临床使用补充抑制剂预防感染的实用考虑.

Anuja Java1, Aruna Subramanian2, Carla Nester3

  • 1Division of Nephrology, Washington University School of Medicine, St. Louis, MO, USA.

Clinical journal of the American Society of Nephrology : CJASN
|February 6, 2026
PubMed
概括

补充抑制剂治疗脏疾病,但增加感染风险. 医疗保健提供者必须实施预防性措施,防止像内炎菌这样的严重感染.

更多相关视频

PRP as a New Approach to Prevent Infection: Preparation and In vitro Antimicrobial Properties of PRP
06:36

PRP as a New Approach to Prevent Infection: Preparation and In vitro Antimicrobial Properties of PRP

Published on: April 9, 2013

22.1K
Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
07:44

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay

Published on: March 12, 2018

10.7K

相关实验视频

Last Updated: Feb 8, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

18.7K
PRP as a New Approach to Prevent Infection: Preparation and In vitro Antimicrobial Properties of PRP
06:36

PRP as a New Approach to Prevent Infection: Preparation and In vitro Antimicrobial Properties of PRP

Published on: April 9, 2013

22.1K
Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
07:44

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay

Published on: March 12, 2018

10.7K

科学领域:

  • 腎臟病學 (nephrology) 是一種醫學專業.
  • 免疫学 免疫学 免疫学
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 补充系统过度激活与严重的脏疾病有关.
  • 用抑制剂向补充系统是改善患者治疗结果的关键研究领域.
  • 已批准的补剂抑制剂包括eculizumab,ravulizumab,avacopan,iptacopan和pegcetacoplan. 这三种药物均为补剂抑制剂.

研究的目的:

  • 审查病治疗中使用的补充抑制剂相关的传染风险.
  • 突出这些疗法安全有效使用的临床考虑因素.

主要方法:

  • 关于补充抑制剂和相关感染的文献综述.
  • 对FDA批准的补充抑制剂用于脏疾病的分析.
  • 关于管理感染风险的临床指导的摘要.

主要成果:

  • 补充抑制剂虽然有效,但会增加严重感染的风险.
  • 封装生物 (脑膜炎菌Neisseria meningitidis,肺炎链球菌Streptococcus pneumoniae,b型流感血球菌Haemophilus influenzae) 是主要关注的问题.
  • 预防措施对于接受补充抑制剂治疗的患者至关重要.

结论:

  • 医疗保健提供者必须意识到并减轻补充抑制剂的感染风险.
  • 安全有效地使用补充抑制剂需要谨慎监测和预防策略.
  • 本综述是临床医生管理患者治疗脏疾病的补充抑制剂的资源.